Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sanada

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Radiation Protection Dosimetry|June 29, 2019
RECENT TRITIUM CONCENTRATION OF MONTHLY PRECIPITATION IN JAPANS Nakasone, A Ishimine, Y Ishizu, et al.
Kokyu to Junkan. Respiration & Circulation|August 1, 1992
[A case of repetitive monomorphic ventricular tachycardia]O Kurusu, S Kudou, J Nomoto, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|February 1, 1987
[A case of complete mediastinal malignant goiter]K Yen, S Abo, T Kudo, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|September 1, 1990
[The correlation between plasma atrial natriuretic polypeptide levels (ANP) and cardio-pulmonary function during the perioperative period of esophageal cancer]Y Kojima, Y Hiramatsu, H Kitade, et al.
Kokyu to Junkan. Respiration & Circulation|October 1, 1984
[Two cases of exercise-induced ventricular tachycardia--catecholamine-induced ventricular tachycardia]M Kawamura, C Komatsu, Y Suzuki, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116)Y Shibouta, Y Inada, M Ojima, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive ratsY Inada, T Wada, Y Shibouta, et al.
Surgery Today|January 1, 1996
Anorectal stenosis in a neonate: report of a case and review of the Japanese literatureY Hamada, T Mori, A Tanano, et al.
Biochemical Pharmacology|July 20, 1993
Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonistM Noda, Y Shibouta, Y Inada, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 1, 1981
[Coagulum pyelolithotomy and coagulum nephrolithotomy (author's transl)]H Ito, T Sanada, M Murakami, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Radiation Protection Dosimetry|June 29, 2019
RECENT TRITIUM CONCENTRATION OF MONTHLY PRECIPITATION IN JAPANS Nakasone, A Ishimine, Y Ishizu, et al.
Kokyu to Junkan. Respiration & Circulation|August 1, 1992
[A case of repetitive monomorphic ventricular tachycardia]O Kurusu, S Kudou, J Nomoto, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|February 1, 1987
[A case of complete mediastinal malignant goiter]K Yen, S Abo, T Kudo, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|September 1, 1990
[The correlation between plasma atrial natriuretic polypeptide levels (ANP) and cardio-pulmonary function during the perioperative period of esophageal cancer]Y Kojima, Y Hiramatsu, H Kitade, et al.
Kokyu to Junkan. Respiration & Circulation|October 1, 1984
[Two cases of exercise-induced ventricular tachycardia--catecholamine-induced ventricular tachycardia]M Kawamura, C Komatsu, Y Suzuki, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116)Y Shibouta, Y Inada, M Ojima, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive ratsY Inada, T Wada, Y Shibouta, et al.
Surgery Today|January 1, 1996
Anorectal stenosis in a neonate: report of a case and review of the Japanese literatureY Hamada, T Mori, A Tanano, et al.
Biochemical Pharmacology|July 20, 1993
Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonistM Noda, Y Shibouta, Y Inada, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 1, 1981
[Coagulum pyelolithotomy and coagulum nephrolithotomy (author's transl)]H Ito, T Sanada, M Murakami, et al.
Pageof 7